TOMI posts strong Q1 2026 BIT solution revenue

TOMI Environmental Solutions reports strong early momentum in its high-margin BIT Solution business for Q1 2026.

(High)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

TOMI Environmental Solutions reports strong early momentum in its high-margin BIT Solution business for Q1 2026. BIT Solution sales have grown annually from $872,380 in 2024 to $1,065,172 in 2025, with first-quarter 2026 sales and orders of about $427,000. Management notes BIT typically generates gross margins above 80%, supporting a recurring revenue model tied to installed SteraMist delivery systems.

The company highlights growing demand for 55-gallon BIT drums, used in automated integration builds, with sales rising from five drums in 2024 to seven in 2025 and an expectation of ten in 2026. Total Q1 2026 orders were about $3.36 million, with preliminary recognized revenue of roughly $1.7 million. Management states this order level positions TOMI to potentially exceed $12 million in revenue for fiscal 2026 while targeting sustained, growing profitability.

Positive

BIT Solution sales rose from $872,380 in 2024 to $1,065,172 in 2025, and reached about $427,000 in Q1 2026, indicating strong growth in a >80%-margin consumable.
Total Q1 2026 orders of roughly $3.36 million and preliminary revenue of about $1.7 million lead management to state the company is positioned to potentially exceed $12 million in 2026 revenue.

Negative

None.

Insights

High-margin consumable growth and record orders support TOMI’s 2026 revenue ambitions.

TOMI is emphasizing the scaling of its Razor and Blade model. Installed SteraMist systems drive recurring demand for BIT Solution, which historically carries gross margins above 80%. BIT sales rose from $872,380 in 2024 to $1,065,172 in 2025, with Q1 2026 adding about $427,000.

Total Q1 2026 orders of roughly $3.36 million and preliminary revenue of around $1.7 million underpin management’s statement that the company is positioned to potentially exceed $12 million in 2026 revenue. Expected growth in 55-gallon drum sales, tied to automated integrations scheduled by year-end, further reinforces the recurring, high-margin component of the model.

The main execution dependencies are continued customer adoption of iHP-based systems and successful conversion of the current order pipeline into recognized revenue. Future company filings and updates will clarify whether these preliminary trends translate into sustained profitability.

Key Figures

BIT Solution sales 2024: $872,380 BIT Solution sales 2025: $1,065,172 BIT Solution Q1 2026: Approximately $427,000 +5 more

8 metrics

BIT Solution sales 2024 $872,380 Annual BIT Solution revenue in 2024

BIT Solution sales 2025 $1,065,172 Annual BIT Solution revenue in 2025

BIT Solution Q1 2026 Approximately $427,000 BIT Solution sales and orders in Q1 2026

BIT gross margin In excess of 80% Historical gross margin on BIT Solution

Q1 2026 total orders Approximately $3,360,000 Total orders produced in Q1 2026

Q1 2026 preliminary revenue Approximately $1.7 million Preliminary recognized revenue for Q1 2026

Potential 2026 revenue Exceed $12 million Management statement on 2026 fiscal year revenue potential

55-gallon drums expected 2026 Ten drums Anticipated BIT 55-gallon drum sales in 2026

Key Terms

Razor and Blade business model, Binary Ionization Technology, ionized Hydrogen Peroxide, recurring revenue, +1 more

5 terms

Razor and Blade business model financial

"TOMI employs a Razor and Blade business model for iHP decontamination."

A razor and blade business model is one in which a company sells a low-cost or one-time core product and makes most of its profit from repeat purchases of complementary items, parts, or services required to keep the product working. For investors, this matters because it can create steady, predictable follow-on revenue, high customer switching costs and strong margins over time—similar to buying a cheap printer but paying repeatedly for expensive ink cartridges.

Binary Ionization Technology technical

"its premier Binary Ionization Technology® (BIT™) platform."

Binary ionization technology is a method that uses controlled electrical charges to change or activate substances at a molecular level, often for purposes like sterilization or purification. For investors, it matters because innovations in this technology can lead to new products or processes that improve efficiency and safety, potentially creating new market opportunities and driving growth in related industries.

ionized Hydrogen Peroxide technical

"to produce a fog of ionized Hydrogen Peroxide (iHP™)."

Ionized hydrogen peroxide is a form of hydrogen peroxide that has been electrically charged to create reactive particles. This process enhances its ability to kill germs and break down contaminants, making it more effective for cleaning and disinfecting. For investors, understanding its use and effectiveness can be important when evaluating companies involved in health, sanitation, or innovative cleaning technologies.

recurring revenue financial

"contribute to ongoing high-margin recurring revenue."

Revenue that a company expects to receive on a regular, predictable basis from ongoing sources such as subscriptions, service contracts, or repeat customer purchases. It matters to investors because it provides steadier cash flow and makes future earnings easier to forecast—like a landlord collecting monthly rent instead of one-off sales—supporting higher valuations and lower risk when those payments are reliable and customers tend to stay.

forward-looking statements regulatory

"This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How did TOMI (TOMZ) BIT Solution sales trend into Q1 2026?

TOMI’s BIT Solution sales increased from $872,380 in 2024 to $1,065,172 in 2025, then generated about $427,000 in sales and orders during Q1 2026. Management highlights BIT as a high-margin consumable supporting recurring revenue from its installed SteraMist systems.

What margins does TOMI (TOMZ) earn on its BIT Solution consumable?

TOMI states its BIT Solution has historically generated gross margins above 80%. This is significantly higher than the company’s consolidated gross margins and is central to its Razor and Blade model, where installed SteraMist hardware drives ongoing high-margin consumable demand.

What were TOMI (TOMZ) total orders and revenue for Q1 2026?

For Q1 2026, TOMI reports total orders of approximately $3.36 million and preliminary recognized revenue of about $1.7 million. These figures are described as preliminary and unaudited but provide an early view of the company’s growing demand pipeline and revenue conversion.

How many 55-gallon BIT drums is TOMI (TOMZ) expecting to sell in 2026?

TOMI sold five 55-gallon BIT drums in 2024 and seven in 2025, and it anticipates selling ten drums in 2026. These drums support automated SteraMist integration builds and contribute to ongoing, high-margin recurring revenue tied to installed systems.

What revenue outlook does TOMI (TOMZ) reference for fiscal 2026?

Based on about $3.36 million in Q1 2026 orders, TOMI states it is positioned to potentially exceed $12 million in revenue for the 2026 fiscal year. This statement reflects management’s view and is characterized as forward-looking, subject to usual business risks.

What is TOMI (TOMZ) Razor and Blade business model with SteraMist and BIT?

TOMI sells SteraMist delivery systems as the “razor” and its proprietary BIT Solution as the “blade.” Hardware installations drive recurring demand for BIT, a high-margin consumable, aiming to build sustained profitability from repeat solution sales after initial equipment placement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/15/2026 - 09:20 AM

EXHIBIT 99.1

TOMI Reports Strong Q1 2026 Sales of High-Margin BIT Solution, Indicating Positive Growth Trends

Frederick, MD – April 14, 2026 – TOMI Environmental Solutions, Inc.^® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection/decontamination solutions reports preliminary unaudited BIT Solution revenue for the first quarter of 2026. TOMI employs a Razor and Blade business model for iHP decontamination. The Company sells a durable primary delivery system (the “razor”) under the SteraMist brand, at a competitive price point. Delivery system sales drive ongoing demand for our EPA- registered BIT solution, a high-margin consumable (the "blade"). BIT Solution sales have historically generated gross margins in excess of 80%, well above TOMI’s historical consolidated gross margins.

Since 2024, BIT solution sales have shown steady annual growth, increasing from $872,380 in 2024 to $1,065,172 in 2025. In the first quarter of 2026, BIT solution sales and orders totaled approximately $427,000.

TOMI sells 55-gallon drums, which play a crucial role in SteraMist automated integration builds and contribute to ongoing high-margin recurring revenue. Historically, sales of these 55-gallon drums occur in the latter half of the year; in 2024, TOMI sold five (5) 55-gallon drums, increasing to seven (7) drums in 2025. This year, TOMI anticipates selling ten (10) drums, driven by a growing pipeline of automated integration builds scheduled for delivery by year-end.

As noted in the Company’s previous press release, total orders produced in the first quarter amounted to approximately $3,360,000 million, with preliminary figures indicating approximately $1.7 million in recognized revenue for the quarter. This $3.3 million in orders positions TOMI to potentially exceed $12 million in revenue for the 2026 fiscal year.

Dr. Halden Shane, CEO of TOMI Environmental Solutions commented, “Our razor-razor blade model is beginning to show tangible results after years of growing the installed base of SteraMist delivery systems with customers. The primary goal of the Company is to achieve sustained and growing profitability. The timeline for achieving this has always been largely dependent on how quickly the iHP technology can foster customer adoption, establishing a recurring revenue stream from our proprietary BIT Solution sales, a high-margin consumable which offsets the initial hardware sales.”

About TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®

TOMI™ Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.

TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.

For additional information, please visit https://www.steramist.com or contact us at info@tomimist.com.

Forward-Looking Statements

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to preliminary financial results, including preliminary revenue information, estimated open orders, BIT Solution sales, and estimated total integration pipeline, expected revenue growth in 2026 and beyond, TOMI’s products and services to serve the life sciences sector, and the ability to complete delivery of products and services pursuant to purchase orders. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These may include, but are not limited to, our ability to acquire new customers and expands sales; our projected revenue and revenue recognized from anticipated future purchase orders, invoiced orders, and contracts, our ability to maintain and manage growth and generate sales (equipment and consumable), our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

INVESTOR RELATIONS CONTACT:

John Nesbett/Zach Nevas

IMS Investor Relations

tomi@imsinvestorrelations.com

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

6 documents

Press Releases

EX-99.1 PRESS RELEASE 10.9 KB

TOMI posts strong Q1 2026 BIT solution revenue